# Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control

> **NCT01715311** · PHASE4 · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Indacaterol
- **DRUG:** Placebo to tiotropium
- **DRUG:** Tiotropium
- **DRUG:** Placebo to indacaterol

## Key facts

- **NCT ID:** NCT01715311
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-11
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** withdrawn prior to patient recruitment
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715311, "Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01715311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*